ALERTS: GENERAL - EUROPEAN UNION - HEALTHCARE - COMPETITION POLICY - COVID-19

COVID-19: The European Commission issues second comfort letter to address current slowdowns in COVID-19 vaccine production and to accelerate the use of additional capacity available across Europe

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. On 26 March 2021, the Commission published a new comfort lettersigned by the Director General of DG Comp, Olivier Guersent. This time it concerns the organisation of a pan-European online business forum which takes place from 29 to 31 March 2021 and is entitled "Matchmaking Event - Towards COVID-19 vaccines upscale production" The event, which the organisers have placed under the aegis of the European Commission as host of the event, aims to address bottlenecks in the current production of COVID-19 vaccines and to accelerate the use of the additional capacity available across Europe, by facilitating exchanges between participating

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • L’actu-concurrence (Paris)

Quotation

Alain Ronzano, COVID-19: The European Commission issues second comfort letter to address current slowdowns in COVID-19 vaccine production and to accelerate the use of additional capacity available across Europe, 25 March 2021, Concurrences N° 1-2021, Art. N° 99958, www.concurrences.com

Visites 55

All reviews